Royce Mohan, Ph.D.Professor, Neuroscience
|
- Overview
- Education & Training
- Committees & Organizations
- Research
- Research Opportunities
- Lab Rotations
- Publications
- Presentations
The Mohan lab studies the process of injury and disease-related fibrosis in both the cornea and retina that leads to blindness. The lab is especially interested in druggable targets that could be potential avenues for drug discovery and translated into ocular therapeutics.
Degree | Institution | Major |
---|---|---|
B.Sc. | Loyola College | Chemistry |
M.Sc. | Indian Institute of Technology | Chemistry |
Ph.D. | The Ohio State University | Biochemistry |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Postdoctoral | Harvard Medical School/Brigham and Women’s Hospital | Rheumatology and Immunology |
Postdoctoral | Tufts University School Medicine | Ophthalmology |
Postdoctoral | New England Medical Center | Ophthalmology |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Dean's Mentor Award | UConn School of Medicine |
DEAN'S MENTOR AWARD | UCONN SCHOOL OF MEDICINE |
John A. and Florence Mattern Solomon Endowed Chair in Vision Biology and Eye Diseases | University of Connecticut Health Center |
President's Award for Excellence in Research | Fight for Sight Foundation, Inc. |
Travel Fellowship to Paris, France | International Society for Eye Research |
National Eye Institute Fellowship, Woods Hole, MA | National Eye Institute, NIH |
Monsanto Biotechnology Fellowship, Research in Chemical and Life Sciences | Monsanto, St. Louis, Missouri |
Winner of 16th Annual ICSABER Graduate Research Forum in Basic Science | Ohio State University |
MCM Scholarship for Chemistry, 1984-86 | Indian Institute of Technology |
Merit Certificate, Chemistry Quiz Competition | Royal Society of Chemists, London |
B.S. Scholarship for Chemistry, India, 1981-84 | Army Educational Fund |
Name & Description | Category | Role | Type | Scope | Start Year | End Year |
---|---|---|---|---|---|---|
Biomedical Sciences Graduate Program Committee | Advisory Committee | Chair | UConn Health | University | 2022 | |
UCH Graduate School Diversity, Equity, and Inclusion Committee | Advisory Committee | member | UConn Health | University | 2021 | |
Faculty recruitment and selection committee | Advisory Committee | member | UConn Health | University | 2021 | 2022 |
Biomedical Sciences Graduate Program Committee | Advisory Committee | Vice Chair | UConn Health | University | 2020 | 2022 |
Associate Editor, Journal of Neuroscience Research | Editorial Board | Manuscript review and management | External | International | 2019 | |
Medical Student Research Proposal Advisory Member | Advisory Committee | Scientific project assessment | UConn Health | University | 2019 | |
Neuroscience area of concentration | Education Committee | Assoc. Program Director | UConn Health | University | 2018 | 2020 |
Medical School Item Writing & Review Committee | Education Committee | medical school exam assessment | UConn Health | University | 2018 | 2020 |
Faculty Development Advisory Committee | Advisory Committee | Member | UConn Health | University | 2016 | |
Health Center Research Advisory Council (HCRAC) | Advisory Committee | member | UConn Health | University | 2016 | |
Graduate Student and MD-PhD Recruitment | Education Committee | Applicants interview and evaluation | UConn Health | University | 2010 |
Study of Muller glia in retinal degeneration; myofibroblasts and Schwann cells in corneal nerve regeneration, pain and fibrosis; Novel in vivo imaging probes for type III intermediate filaments.
The Mohan lab is interested in how the human eye when subjected to injury or afflicted by disease can be healed. We study two aspects of the eye; the clear transparent cornea and the neurosensory retina that is an extension of the CNS. In the cornea, a current a focus of the lab is the study of myofibroblasts, a differentiated cell type that drives corneal fibrosis leading to blindness. We discovered that overexpression of the type III intermediate filament protein vimentin drives corneal fibrosis, and our search of a potent inhibitor of fibrosis led to the discovery of the small molecule withaferin A that binds to vimentin. This small molecule is the first in class inhibitor for the IF proteins, and hence, we have developed fluorescent analogs as imaging probes to study vimentin and, its related protein glial fibrillary acidic protein in the retina. Mechanistic studies to unravel signaling mechanisms in corneal fibrosis are also currently being pursued. Another important cell type of the cornea is the Schwann cell that ensheaths and supports corneal axons. Following axonal lesions, such as after surgical procedures (e.g. LASIK or corneal transplants), corneal nerve regeneration becomes aberrant and often is incomplete. To understand the involvement of corneal Schwann cells in nerve repair, our lab has unraveled the global transcriptome of corneal Schwann cells and novel druggable targets that have been identified by bioinformatics are being studied.
At the posterior end of the eye, we are interested in the process of retinal degeneration focusing on the disease known as age-related macular degeneration (AMD). AMD is the world’s most common form of CNS neurodegeneration affecting over 10 million people in the US alone. Investigating Muller glial cells to the generalized stress response known as reactive gliosis, we have discovered a novel druggable target, peptidyl arginine deiminase 4 (PAD4) that is associated with retinal pathology. PAD4 catalyzes a posttranslational modification of proteins known as citrullination. We are now investigating the role of PAD4 in AMD and its functional deficiency induced by genetic and pharmacological means is being tested in animal models. Ultimately, we would like to illuminate targets such as PAD4 for drug development towards our overarching goal of developing a treatment for AMD patients.
Research opportunities to study corneal Schwann cells in animal models of injury and regeneration
Research opportunities to study the retina in age-related macular degeneration animal models of fibrosis
Accepting Lab Rotation Students: Fall 2022 and Spring 2023
Journal Articles
-
ER-stress response in retinal Müller glia occurs significantly earlier than amyloid pathology in the Alzheimer's mouse brain and retina.
Glia 2024 Jun;72(6):1067-1081
-
A corneo-retinal hypercitrullination axis underlies ocular injury to nitrogen mustard.
Experimental eye research 2023 Jun;231109485
-
Peptidyl arginine deiminase 4 deficiency protects against subretinal fibrosis by inhibiting Müller glial hypercitrullination.
Journal of Neuroscience Research. 10.1002/jnr.25158. 2022 Dec;
-
Compartmentalized citrullination in Muller glial endfeet during retinal degeneration.
Proceedings of the National Academy of Sciences of the United States of America. 2022 Mar 1;119(9):e2121875119. 2022 Jan;119(9):
-
Corneal nonmyelinating Schwann cells illuminated by single-cell transcriptomics and visualized by protein biomarkers.
Journal of Neuroscience Research 2021 Jan;99(3):731-749
-
Eye of the beholder: Rare Eye Diseases in Focus. Royce Mohan served as the guest Editor for this special edition and provided the featured cover
Journal of Neuroscience Research 2019 Jan;97(1):3-6
-
Expression of peptidylarginine deiminase 4 in an alkali injury model of retinal gliosis.
Biochemical and biophysical research communications 2017 May;487(1):134-139
-
Citrullination of glial intermediate filaments is an early response in retinal injury.
Molecular vision 2016 Sep;221137-1155
-
Early retinal inflammatory biomarkers in the middle cerebral artery occlusion model of ischemic stroke.
Molecular vision 2016 Jan;22575-88
-
Vimentin Phosphorylation Underlies Myofibroblast Sensitivity to Withaferin A In Vitro and during Corneal Fibrosis.
PloS one 2015 Jan;10(7):e0133399
-
Withaferin A effectively targets soluble vimentin in the glaucoma filtration surgical model of fibrosis.
PloS one 2013 Jan;8(5):e63881
-
Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentin.
The Journal of biological chemistry 2012 Jan;287(2):989-1006
-
A robust model for simultaneously inducing corneal neovascularization and retinal gliosis in the mouse eye.
Molecular vision 2011 Jan;171901-8
-
Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis.
The Journal of biological chemistry 2010 Mar;285(10):7657-69
-
The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin.
Chemistry & biology 2007 Jun;14(6):623-34
-
Eyes wide s-flt: clearly, avascular fidelity is a vascular endothelial growth factor family affair.
The British journal of ophthalmology 2007 Apr;91(4):412-3
-
Development of withaferin A analogs as probes of angiogenesis.
Bioorganic & medicinal chemistry letters 2006 May;16(10):2603-7
-
Withaferin A is a potent inhibitor of angiogenesis.
Angiogenesis 2004 Jan;7(2):115-22
-
Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration.
The Journal of biological chemistry 2002 Jan;277(3):2065-72
-
Role of the Lewis(x) glycan determinant in corneal epithelial cell adhesion and differentiation.
The Journal of biological chemistry 2001 Jun;276(24):21714-23
-
The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest.
Proceedings of the National Academy of Sciences of the United States of America 2000 Nov;97(23):12782-7
-
Pax-6 expression and activity are induced in the reepithelializing cornea and control activity of the transcriptional promoter for matrix metalloproteinase gelatinase B.
Developmental biology 2000 Jun;222(1):41-54
-
Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B.
The Journal of biological chemistry 2000 Apr;275(14):10405-12
-
Small-molecule inhibitors of the cell cycle.
Current opinion in chemical biology 2000 Feb;4(1):47-53
-
Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones.
Chemistry & biology 1999 Nov;6(11):811-22
-
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.
Proceedings of the National Academy of Sciences of the United States of America 1999 Aug;96(18):10403-8
-
Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling.
The Journal of biological chemistry 1998 Oct;273(40):25903-14
-
Molecular cloning of the E-cadherin cDNAs from rabbit corneal epithelium.
Current eye research 1995 Dec;14(12):1136-45
-
Developmental and tissue-specific expression of a tomato anionic peroxidase (tap1) gene by a minimal promoter, with wound and pathogen induction by an additional 5'-flanking region.
Plant molecular biology 1993 Jun;22(3):475-90
-
Induction of a tomato anionic peroxidase gene (tap1) by wounding in transgenic tobacco and activation of tap1/GUS and tap2/GUS chimeric gene fusions in transgenic tobacco by wounding and pathogen attack.
Plant molecular biology 1993 Jan;21(2):341-54
-
Chemical characterization of stress-induced vascular coating in tomato.
Plant physiology 1991 Oct;97(2):528-36
-
Differential Activation of Expression of a Suberization-Associated Anionic Peroxidase Gene in Near-Isogenic Resistant and Susceptible Tomato Lines by Elicitors of Verticillium albo-atratrum.
Plant physiology 1990 Jan;92(1):276-80
-
Molecular Basis of the Early Events in Plant-Fungus Interactions.
Genome 1989 Jan;31342-349
-
Phenylthiomethylstannylation of Silyl Ethers and Silyl Dienol Ethers.
Tetrahedron Letters 1989 Jan;30239-242
-
LMP2-specific inhibitors: chemical genetic tools for proteasome biology.
Chemistry & Biology 14(4):419-30
-
Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: potential application to choroidal neovascularization.
Investigative ophthalmology & visual science 47(9):4138-45
-
Sustained activation of ERK1/2 MAPK in Schwann cells causes corneal neurofibroma.
Journal of Neuroscience Research 95(9):1712-1729
-
Use of PROTACS as molecular probes of angiogenesis.
Bioorganic & medicinal chemistry letters 15(11):2724-7
Book Chapters
-
The Use of Withaferin A to Study Intermediate Filaments.
Methods in enzymology 2016 Jan;187-218
-
Herbal Medicinal Products as Anti-Angiogenic Agents
Evaluation of Herbal Medicinal Products-Perspectives of Quality, Safety and Efficacy 2009 Jan;174-182
-
Regulation of Matrix Metalloproteinase Gene Expression
Matrix Metalloproteinase 1998 Jan;300-356
-
Sclera
Cornea 1997 Jan;29-40
-
Mutual Triggering of Gene Expression in Plant-Fungus Interactions
Advances in Molecular Genetics of Plant-Microbe Interactions 1990 Jan;242-249
Abstracts
-
A One-Two Punch to Corneal Fibrosis and Retinal Gliosis in Alkali Injury
Toxicology Letters (Special Issue) 2020 Oct;331 (1)(1):1-22; S12-13
Other
-
Methods of use for Intermediate Filament Protein Probes
United States Patent 10,690,683 2020 Jun;
Reviews
-
Proteolytic mechanisms in corneal ulceration and repair.
Archives of dermatological research 1998 Jul;290 SupplS12-23
-
Plant peroxidase gene expression and function.
Biochemical Society transactions 1992 May;20(2):333-7
Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
---|---|---|---|---|
Targeting Citrullination in Ocular Chemical Injury | Talk | 2023 | (August 21-23) Bethesda, MD | |
Elias Mullane, Sarah I. Palko, Hui Sun, Paola Bargagna-Mohan, Royce Mohan. Hypercitrullination in a Genetic Model of Spontaneous Retinal Degeneration and Laser Injury Model of Gliosis. Investigative Ophthalmology & Visual Science. June 2022, Vol.63, 1943 – F0361 | Poster | Associationa for Research in Vision and Ophthalmology | 2022 | May 1-4, 2022, Denver, CO |
Ricky Paramo, Royce Mohan, Paola Bargagna-Mohan. Unraveling how Corneal Schwann cells Affect Axonal Regeneration. Investigative Ophthalmology & Visual Science. June 2022, Vol.63, 114 – A0212. | Poster | Associationa for Research in Vision and Ophthalmology | 2022 | May 1-4, 2022, Denver, CO |
Royce Mohan, Ezigbobiara Umejiego and Paola Bargagna-Mohan. Targeting citrullination in ocular chemical injury. | Talk | 15th Annual NIH Countermeasures Against Chemical Threats Symposium | 2022 | June 21-23, 2022. New Orleans, LA |
E. Umejiego, P. Bargagna-Mohan, R. Mohan. Retinal Gliosis and Hypercitrullination in a Novel Nitrogen Mustard Corneal Injury Model. Investigative Ophthalmology & Visual Science. June 2022, Vol.63, 685 – F0139. doi: | Poster | Associationa for Research in Vision and Ophthalmology | 2022 | May 1-4, 2022, Denver, CO |
E. Mullane, S.I. Palko, H. Sun, P. Bargagna-Mohan, R. Mohan. Hypercitrullination in a Genetic Model of Spontaneous Retinal Degeneration and Laser Injury Model of Gliosis. Investigative Ophthalmology & Visual Science. June 2022, Vol.63, 1943 – F0361. doi: | Poster | Associationa for Research in Vision and Ophthalmology | 2022 | May 1-4, 2022, Denver, CO |
R. Paramo, R. Mohan, P. Bargagna-Mohan. Unraveling how Corneal Schwann cells Affect Axonal Regeneration. Investigative Ophthalmology & Visual Science. June 2022, Vol.63, 114 – A0212. doi: | Poster | Associationa for Research in Vision and Ophthalmology | 2022 | May 1-4, 2022, Denver, CO |
Royce Mohan, E. Umejiego, Paola Bargagna-Mohan. Targeting citrullination in ocular chemical injury. | Talk | 15th Annual NIH Countermeasures Against Chemical Threats Symposium | 2022 | June 21-23, 2022; New Orleans, LA |
Ezigbobiara Umejiego, Paola Bargagna-Mohan, Royce Mohan. Retinal Gliosis and Hypercitrullination in a Novel Nitrogen Mustard Corneal Injury Model.Investigative Ophthalmology & Visual Science. June 2022, Vol.63, 685 – F0139 | Poster | Association for Research in Vision and Ophthalmology | 2022 | May 1-4, 2022, Denver, CO |
Gwendolyn Schultz, Royce Mohan, Paola Bargagna-Mohan. A glial point of view: investigating corneal Schwann cells in ex vivo murine organ and whole-eye cultures.Investigative Ophthalmology & Visual Science June 2021, Vol.62, 926. | Talk | Association for Research in Vision and Ophthalmology | 2021 | virtual; May 1-7, 2021 |
Sarah Ilona Palko; Nicholas Saba; Benjamin D Nicholas; Yosuke Nagasaka; Jayakrishna Ambati; Bradley D Gelfand; Akihito Ishigami; Paola Bargagna-Mohan; Royce Mohan.Genetic ablation of PAD4 in the Accelerated Mouse Model of AMD Results in Reduced Citrullinated Products.Investigative Ophthalmology & Visual Science June 2021, Vol.62, 2726. | Talk | Association for Research in Vision and Ophthalmology | 2021 | virtual; May 1-7, 2021 |
Royce Mohan; Gwendolyn Schultz; Connor Treadwell; Paul Robson; Paola Bargagna-Mohan. The Nerve of Corneal Schwann Cells! Illuminated by Single Cell RNA Transcriptomics. Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2928 | Poster | Association for Research in Vision and Ophthalmology | 2020 | Baltimore, MD - virtual May 3-7, 2020 |
Royce Mohan, John Wizeman and Paola Bargagna-Mohan. One-Two Punch to Corneal Fibrosis and Retinal Gliosis in Alkali InjuryDevelopment of Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity (Bethesda, MD) Feb 25-26, 2020 | Talk | Develop Med Countermeasures: Acute and Chronic Effects of Ocular Chemical | 2020 | Bethesda, MD (in person) Feb 25-26, 2020 |
Gwendolyn Schultz, Paola Bargagna-Mohan, Bruce Rheaume, Paul Robson, and Royce Mohan. An Eye for Detail: Examining the Role of Corneal Schwann cells.New England Ophthalmological Society Annual Conference. NEOS abstract June 5, 2020. | Poster | NEOS | 2020 | Boston, MA - virtual June 5, 2020 |
Paola Bargagna-Mohan, Connor Treadwell, Katherine S. Given, Wendy B. Macklin, and Royce Mohan. The Proteolipid Protein 1 Promoter Drives Reporter Gene Expression in Corneal Schwann Cells. Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3554 | Poster | ARVO | 2020 | Baltimore, MD - virtual May 3-7, 2020 |
Sarah Ilona Palko, Nicholas Saba, Humza Zaidi, Benjamin D. Nicholas, Yosuke Nagasaka, Jayakrishna Ambati, Bradley D. Gelfand, Paola Bargagna-Mohan, and Royce Mohan. PAD4 is Upregulated in the Accelerated Mouse Model of AMD and Human AMD. Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3689. | Poster | Association for Research in Vision and Ophthalmology | 2020 | Baltimore, MD - virtual May 3-7, 2020 |
PAD4 in the Accelerated Mouse Model of AMD and Human AMD. | Poster | Association for Research in Vision and Ophthalmology | 2020 | MD |
The Proteolipid Protein 1 Promoter Drives Reporter Gene Expression in Corneal Schwann Cells. | Poster | Association for Research in Vision and Ophthalmology. | 2020 | MD |
Gwendolyn Schultz, Maria Lopez, Royce MOHAN and Paola Bargagna-Mohan. Corneal Schwann Cells Differentiate into Myofibroblasts After Injury | Poster | Association for Research in Vision and Ophthalmology | 2019 | Vancuver, Canada |
Paola Bargagna-Mohan, Akihiro Ishii, Gwendolyn Schultz, Maria Lopez, Rashmi Bansal and Royce MOHAN. mTOR Regulates the Differentiation of Corneal Schwann cells into Myofibroblasts | Talk | Association for Research in Vision and Ophthalmology | 2019 | Vancuver, Canada |
Sarah IIona Palko, Nicholas Saba, Megan Rouillard, Paola Bargagna-Mohan and Royce MOHAN. PAD4: A Potential Target for Gliosis in Age Related Macular Degeneration | Poster | Association for Research in Vision and Ophthalmology | 2019 | Vancuver, Canada |
Paola Bargagna-Mohan, Sarah I. Palko, Shaan Kamal, and Royce MOHAN*. Corneal Myofibroblasts: Evidence of Differentiation from Adult Schwann Cells in Injury | Talk | Gordon Conference on Cornea and Ocular Surface Biology and Pathology | 2018 | Ventura, CA |
Paola Bargagna-Mohan, Sarah I. Palko, Shaan Kamal, and Royce MOHAN*. Corneal Myofibroblasts: Evidence of Differentiation from Adult Schwann Cells in Injury | Poster | Gordon Conference on Cornea and Ocular Surface Biology and Pathology | 2018 | Ventura, CA |
Differential Corneal Fibrosis in Desmin Deficiency | Poster | Association for Research in Vision and Ophthalmology | 2017 | Baltimore, MD |
A Novel Vimentin Probe Illuminates Mitochondrial Dynamics | Talk | Association for Research in Vision and Ophthalmology | 2017 | Baltimore, MD |
Expression and Inhibition of Peptidyl Arginine Deiminase (PAD) Enzymes in Eye Injury | Talk | Association for Research in Vision and Ophthalmology | 2017 | Baltimore, MD |
Vimentin Phosphorylation Patterns Differentiate Corneal Fibroblasts from Myofibroblasts In Vitro and During Fibrosis | Talk | Association for Research in Vision and Ophthalmology | 2015 | Denver, CO |
A Novel Mouse Model of Corneal Neurofibroma in NF-1 | Talk | Association for Research in Vision and Ophthalmology | 2014 | Orlando, FL |